Scrip Articles

NZ King Salmon Limited – 2022 Annual Meeting Report

NZ King Salmon Limited Annual Meeting Report, June 27th 2022 Click here for NZSA Assessment and Voting intentions Metric 2022 ($m) 2021 ($m – 7 months) Change Revenue $174.5m $95.2m n/a NPAT -$73.2m -$7.1m n/a EPS -$0.052 -$0.05 n/a Gross Margin 7% 15% -51% Inventory Turnover 4.61 2.53 n/a PE Ratio n/a n/a n/a Current…
Read more

Pushpay Holdings Limited – 2022 Annual Meeting Report

Pushpay Holdings Limited Annual Meeting Report, June 16th 2022 Click here for NZSA Assessment and Voting intentions Metric 2021 (US$) 2020 (US$) Change Revenue $202.8m $181.0m 12% EBITDAF2 $55.0m $58.9m -7% NPAT $33.4m $31.2m 7% EPS1 $0.029 $0.027 7% PE Ratio3 29 39   Current Ratio 0.76 1.21 -38% Debt Equity 0.61 0.25 148% Operating…
Read more

Scales Corporation Limited – 2022 Annual Meeting Report

Scales Corporation Limited Annual Meeting Report, June 9th 2022 Click here for NZSA Assessment and Voting intentions Metric 2021 2020 Change Revenue $514.6m $470.7m 9% EBITDA $71.6m $56.7m 26% NPAT2 $26.9m $21.0m 28% Gross Profit Margin 22% 22% n/c Inventory Turnover 7.70 7.50 3% EPS12 $0.189 $0.148 28% PE Ratio 25 31   Current Ratio…
Read more

Pushing boundaries at Ryman Healthcare?

As a Ryman Healthcare shareholder, you may have been pleased to see the company recently report an underlying profit of $255 million to 31 March 2022, up 13.6% on last year; a record Australian profit; and the delivery of 711 new units and beds (292 in the first half; 419 in the second half). What…
Read more

A fly on the wall – attending the Australian Shareholders Association (ASA) Conference

Over the past year or so, NZSA has been quietly building a closer working relationship with our friends in Australia. We think that’s important – most of us have a more ‘regional’ outlook in our investment approach when investing in this corner of the world. Like others, though, I do wish that most Australians would…
Read more

What makes a good initial public offering (IPO)?

The key function of any capital market is to raise capital. That is not necessarily well understood by most shareholders as the primary purpose. Indeed, many investors believe that the purpose of a stock market is to facilitate trading and serve the needs of investors. In truth, they are merely ancillary functions that provide credibility…
Read more

Brian Gaynor – we will miss you

On May 16th, we were surprised and saddened to learn of the death of Brian Gaynor earlier that morning. Brian was a staunch supporter of NZSA, with a strong passion for “doing the right thing” for retail shareholders. He was a two-time winner of the Beacon Award (in 2006 and 2020), and shared a passion…
Read more

Asset Plus Limited – 2022 Special Meeting Report

Asset Plus Limited Special Meeting Report, June 3rd 2022 Click here for NZSA Assessment and Voting intentions A virtual only format was an appropriate vehicle for this 30 minute, single issue special meeting to approve the sale of Asset Plus’s ‘lame duck’ unoccupied Graham Street property. Chair, Bruce Cotterill, and Stephen Brown-Thomas, from external manager…
Read more

Event Report – “Intro to Investing”

“Introduction to Investing” – Waikato Branch Waikato Branch Event, May 31st On May 31st, Waikato Branch ran a repeat of an on-line seminar held earlier in the year. Around 200 people had registered for the presentation, titled “Introduction to Investing”. There were two speakers from Craigs Investment Partners as well as two members of the…
Read more

Neuren Pharmaceuticals Limited – 2022 Annual Meeting Report

Neuren Pharmaceuticals Limited Annual Meeting Report, May 30th 2022 Click here for NZSA Assessment and Voting intentions The meeting opened at 2:30pm and was a hybrid meeting. Unfortunately, Neuren did not operate a video presentation so all those online received was an image on the screen and a voice. The chair delivered his address and…
Read more